Ji F - Search Results

Year	Number of Results
1990	1
1991	1
1995	1
1996	2
1997	1
1999	7
2000	4
2001	1
2002	8
2003	7
2004	8
2005	19
2006	21
2007	14
2008	31
2009	34
2010	47
2011	75
2012	72
2013	82
2014	107
2015	111
2016	119
2017	147
2018	164
2019	169
2020	224
2021	210
2022	266
2023	240
2024	272
2025	3

1

Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid.

Wei W, Wong CC, Jia Z, Liu W, Liu C, Ji F, Pan Y, Wang F, Wang G, Zhao L, Chu ESH, Zhang X, Sung JJY, Yu J. Wei W, et al. Among authors: ji f. Nat Microbiol. 2023 Aug;8(8):1534-1548. doi: 10.1038/s41564-023-01418-7. Epub 2023 Jun 29. Nat Microbiol. 2023. PMID: 37386075 Free PMC article.

2

Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.

Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, Ding Y, Ji F, Ho-Kwan Cheung A, Wong N, Yu J. Song Q, et al. Among authors: ji f. J Hepatol. 2023 Dec;79(6):1352-1365. doi: 10.1016/j.jhep.2023.07.005. Epub 2023 Jul 17. J Hepatol. 2023. PMID: 37459922 Free article.

3

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.

Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, Liu W, To KK, Zuo Z, Li X, Zhang X, Sung JJ, Yu J. Fong W, et al. Among authors: ji f. Gut. 2023 Nov 24;72(12):2272-2285. doi: 10.1136/gutjnl-2023-329543. Gut. 2023. PMID: 37770127 Free PMC article.

4

Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement.

Gray ZH, Chakraborty D, Duttweiler RR, Alekbaeva GD, Murphy SE, Chetal K, Ji F, Ferman BI, Honer MA, Wang Z, Myers C, Sun R, Kaniskan HÜ, Toma MM, Bondarenko EA, Santoro JN, Miranda C, Dillingham ME, Tang R, Gozani O, Jin J, Skorski T, Duy C, Lee H, Sadreyev RI, Whetstine JR. Gray ZH, et al. Among authors: ji f. Cell. 2023 Oct 12;186(21):4528-4545.e18. doi: 10.1016/j.cell.2023.09.009. Epub 2023 Oct 2. Cell. 2023. PMID: 37788669 Free PMC article.

5

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.

Su S, Wong WC, Zou Z, Cheng DD, Ong JJ, Chan P, Ji F, Yuen MF, Zhuang G, Seto WK, Zhang L. Su S, et al. Among authors: ji f. Lancet Glob Health. 2022 Feb;10(2):e278-e287. doi: 10.1016/S2214-109X(21)00517-9. Lancet Glob Health. 2022. PMID: 35063115 Free PMC article.

6

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study.

Huang Y, Zhu T, Zhang X, Li W, Zheng X, Cheng M, Ji F, Zhang L, Yang C, Wu Z, Ye G, Lin Y, Wang K. Huang Y, et al. Among authors: ji f. EClinicalMedicine. 2023 Mar 24;58:101899. doi: 10.1016/j.eclinm.2023.101899. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 37007742 Free PMC article.

7

Opioid-free anaesthesia reduces postoperative nausea and vomiting after thoracoscopic lung resection: a randomised controlled trial.

Feng CD, Xu Y, Chen S, Song N, Meng XW, Liu H, Ji FH, Peng K. Feng CD, et al. Among authors: ji fh. Br J Anaesth. 2024 Feb;132(2):267-276. doi: 10.1016/j.bja.2023.11.008. Epub 2023 Dec 1. Br J Anaesth. 2024. PMID: 38042725 Clinical Trial.

8

The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer.

Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, Chan LS, Luk STY, Tong S, Xu J, Zhou Q, Liu D, Su H, Gou H, Cheung AH, To KF, Cai Z, Shay JW, Yu J. Wong CC, et al. Among authors: ji f. Nat Commun. 2022 Jul 8;13(1):3971. doi: 10.1038/s41467-022-31663-z. Nat Commun. 2022. PMID: 35803966 Free PMC article.

9

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.

Zhou Q, Peng Y, Ji F, Chen H, Kang W, Chan LS, Gou H, Lin Y, Huang P, Chen D, Wei Q, Su H, Liang C, Zhang X, Yu J, Wong CC. Zhou Q, et al. Among authors: ji f. Nat Commun. 2023 Aug 4;14(1):4677. doi: 10.1038/s41467-023-39571-6. Nat Commun. 2023. PMID: 37542037 Free PMC article.

10

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR.

Tao WH, Shan XS, Zhang JX, Liu HY, Wang BY, Wei X, Zhang M, Peng K, Ding J, Xu SX, Li LG, Hu JK, Meng XW, Ji FH. Tao WH, et al. Among authors: ji fh. Front Pharmacol. 2022 Jun 14;13:782466. doi: 10.3389/fphar.2022.782466. eCollection 2022. Front Pharmacol. 2022. PMID: 35873574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,200 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,200 results

Results by year